NEET-PG 2013 Practice Questions

Q: Which of the following is a characteristic finding in distal RTA?

Hypercalciuria. ***Hypercalciuria*** - **Hypercalciuria** is a characteristic finding in distal RTA (Type 1), leading to increased calcium in the urine. - This occurs due to reduced **distal tubular reabsorption of calcium** and increased bone resorption from chronic acidosis. *Urine pH 5.5** [1]. - A urine pH < 5.5 would suggest a normal kidney response to systemic acidosis, ruling out distal RTA. *Hypokalemia* - While hypokalemia can occur in distal RTA, it is not always present and is not the most definitive characteristic finding. - **Hypokalemia** is more characteristic of Type 1 RTA due to increased potassium excretion in an attempt to excrete H+ ions. *Nephrolithiasis* - **Nephrolithiasis** (kidney stones) is a common complication of distal RTA due to hypercalciuria and alkaline urine [2]. - However, hypercalciuria is the *reason* for the increased risk of nephrolithiasis, making it a more fundamental characteristic finding.

Q: Which of the following is not a feature of distal renal tubular acidosis

Hyperkalemia. ***Hyperkalemia*** - **Distal renal tubular acidosis (dRTA)** is characterized by impaired acid excretion, leading to metabolic acidosis. The impaired excretion of acid is often accompanied by impaired potassium secretion, resulting in **hypokalemia**, not hyperkalemia. - While hyperkalemia is a feature of **type 4 RTA**, which is characterized by hypoaldosteronism or renal tubular unresponsiveness to aldosterone, it is not a feature of **distal RTA (type 1)**. [1] *Normal anion gap* - **Distal RTA** is a form of **normal anion gap metabolic acidosis**, also known as **hyperchloremic metabolic acidosis**. [1] - The anion gap is calculated as [Na+] - ([Cl-] + [HCO3-]), and in dRTA, the bicarbonate loss is compensated by an increase in chloride, maintaining a normal anion gap. *Renal hypercalciuria* - **Distal RTA** is associated with **impaired acid excretion**, which leads to chronic metabolic acidosis. - This **acidosis** promotes the dissolution of bone, releasing calcium, and decreases tubular reabsorption of calcium, resulting in **hypercalciuria**. *Alkaline urine* - In **distal RTA**, the distal tubule is unable to acidify the urine due to a defect in hydrogen ion secretion. - This leads to a persistent **urine pH > 5.5** (typically alkaline or inappropriately normal) despite systemic acidosis, making it a key diagnostic feature. [1]

Q: Hyperkalemia aciduria is seen in

Type IV Renal Tubular Acidosis. Type IV Renal Tubular Acidosis - This condition is characterized by **hyperkalemia** and **aciduria**, often due to a deficiency in aldosterone or a renal tubular insensitivity to aldosterone [1]. - The impaired aldosterone action leads to reduced potassium excretion and decreased ammonium production, both contributing to **hyperkalemia** and metabolic acidosis [1]. *Type I Renal Tubular Acidosis* - Type I RTA (distal RTA) is characterized by a defect in acid secretion in the distal tubule, leading to **hypokalemia** and metabolic acidosis with persistently high urine pH [2]. - Patients typically excrete an alkaline urine despite systemic acidosis, contrasting with the aciduria seen with hyperkalemia [2]. *Sigmoidocolostomy procedure* - A sigmoidocolostomy can lead to **hyperchloremic metabolic acidosis** due to the reabsorption of chloride and excretion of bicarbonate by the colonic mucosa. - However, it typically causes **hypokalemia** as potassium is secreted into the colonic lumen from the blood. *Type II Renal Tubular Acidosis* - Type II RTA (proximal RTA) involves a defect in bicarbonate reabsorption in the proximal tubule, resulting in **hypokalemia** and metabolic acidosis. - The kidney's ability to acidify urine is still largely intact in the distal nephron once the bicarbonate buffer system is overwhelmed.

Q: A diabetic patient presents with hyperkalemia and urinary pH < 5.5. What is the MOST likely underlying cause?

Type IV RTA. ***Type IV RTA*** - Patients with **diabetes mellitus** frequently develop **hyporeninemic hypoaldosteronism**, leading to Type IV RTA [1]. - This condition is characterized by **hyperkalemia** and **acidosis** with a paradoxically low urinary pH (typically < 5.5). *Uremia* - **Uremia** can cause hyperkalemia and acidosis, but it is a broader term for severe kidney failure and not the most specific underlying cause for the given urinary findings. - While patients with uremia can have aciduria, the combination of **diabetic hyperkalemia** and acid urine points more directly to a specific tubular defect. *Primary hyperaldosteronism* - **Primary hyperaldosteronism** is characterized by **hypertension**, **hypokalemia**, and metabolic alkalosis, which is the opposite of the patient's presentation [1]. - This condition involves excessive aldosterone production, leading to increased potassium excretion [1]. *Type I Renal tubular acidosis* - **Type I RTA** (distal RTA) is characterized by the inability to acidify urine, resulting in a **urinary pH > 5.5** despite systemic acidosis [1]. - While it can cause hypokalemia (due to increased distal K+ secretion) and acidosis, the elevated urinary pH is a key differentiating factor from this patient's presentation [1].

Q: Calciphylaxis is a severe life-threatening condition. Which of the following is most commonly associated with it?

End stage Renal disease. ***End stage Renal disease*** - Calciphylaxis frequently occurs in patients with **end-stage renal disease**, primarily associated with **secondary hyperparathyroidism** [1] and **calcium-phosphate imbalance**. - It leads to **cutaneous ischemia** and necrosis, often requiring aggressive management due to its high **mortality rate**. *Parathyroidectomy* - While parathyroidectomy may affect calcium levels, it is not directly linked to calciphylaxis. - Calciphylaxis more commonly develops due to underlying **chronic renal failure** [1] rather than surgical interventions. *Hyperthyroidism* - Hyperthyroidism primarily causes symptoms related to metabolism, **thyroid hormone excess**, and does not lead to calciphylaxis. - There is no direct correlation between hyperthyroid states and the pathophysiology of calciphylaxis. *Medullary carcinoma thyroid* - This condition involves **medullary thyroid carcinoma**, associated with calcitonin production and does not cause calciphylaxis. - Patients typically experience **thyroid-related symptoms** rather than the vascular complications seen in calciphylaxis.

Q: What is the primary clinical feature of Henoch-Schonlein purpura?

Skin rash characterized by palpable purpura. ***Skin rash characterized by palpable purpura*** - **Palpable purpura** is the hallmark cutaneous manifestation of **Henoch-Schonlein purpura (HSP)**, a small-vessel vasculitis [1]. - This rash typically appears on the **lower extremities and buttocks**, reflecting the deposition of IgA in vessel walls [1]. *Abdominal pain due to vasculitis* - While **abdominal pain** is a common feature of HSP due to gastrointestinal vasculitis, it is not considered the primary clinical feature [1]. - Gastrointestinal involvement can manifest with pain, bleeding, and intussusception, but the **skin rash** is more consistently present and diagnostic. *Joint pain associated with the condition* - **Arthralgia** or **arthritis** (joint pain) is seen in a significant number of HSP patients, particularly in the knees and ankles. - However, it is a secondary manifestation, and not the **defining primary sign** of the disease. *Kidney involvement in the disease* - **Renal involvement**, presenting as hematuria and proteinuria, occurs in about one-third of HSP cases and can lead to serious long-term complications. - Despite its significance for prognosis, **kidney disease** is a later and not universally present feature, making the rash the most critical initial diagnostic clue.

Q: Interstitial nephritis is common with

Nonsteroidal anti-inflammatory drugs (NSAIDs). ***Nonsteroidal anti-inflammatory drugs (NSAIDs)*** - **NSAIDs** are a known cause of **acute interstitial nephritis** (AIN), an inflammatory condition affecting the tubules and interstitium of the kidney [1]. - This adverse reaction often manifests as **fever**, **rash**, **eosinophilia**, and **acute kidney injury**, typically 7-10 days after drug exposure. *Black water fever* - **Blackwater fever** is a severe complication of **malaria**, characterized by massive hemolysis leading to **hemoglobinuria**, which darkens the urine. - It primarily causes **acute kidney injury** through **acute tubular necrosis** due to hemoglobin precipitation in the renal tubules, not interstitial nephritis. *Rhabdomyolysis* - **Rhabdomyolysis** involves the breakdown of muscle tissue, releasing myoglobin into the bloodstream, which is toxic to the kidneys. [1] - This condition leads to **acute kidney injury** predominantly through **acute tubular necrosis** due to myoglobin casts obstructing tubules and direct toxicity, not interstitial inflammation. *Tumor lysis syndrome* - **Tumor lysis syndrome** occurs when large numbers of cancer cells are rapidly destroyed, releasing intracellular contents like potassium, phosphate, and nucleic acids. - The high concentration of **uric acid** and **phosphate** in the renal tubules leads to crystal formation, causing **acute kidney injury** primarily through **acute uric acid nephropathy** and **phosphate nephropathy**, rather than interstitial nephritis [1].

Q: What is the recommended rate of correction for sodium deficit in patients with chronic hyponatremia?

0.5 mmol/hour. ***0.5 mmol/hour*** [1] - This rate of correction is recommended to avoid **osmotic demyelination syndrome (ODS)**, also known as central pontine myelinolysis [1]. - The aim is to correct the sodium deficit gradually, with a maximum increase not exceeding **8-10 mmol/L in any 24-hour period** [1]. *1 mmol/hour* - This rate is generally considered too rapid for chronic hyponatremia and increases the risk of **osmotic demyelination syndrome**. - While acceptable in some acute severe cases, it is typically avoided in chronic settings where the brain has adapted to lower osmolality. *1.5 mmol/hour* - This rate would lead to an even faster correction of sodium, significantly elevating the risk of **osmotic demyelination syndrome**. - It would result in a correction of 36 mmol/L over 24 hours, far exceeding the recommended daily limit of 8-10 mmol/L. *2.0 mmol/hour* - Such a rapid correction rate is highly dangerous and almost guarantees the development of **osmotic demyelination syndrome**. - This aggressive correction would lead to severe brain injury due to rapid osmotic shifts.

Q: What is the recommended time frame for completing a blood transfusion after initiation?

1-4 hours. ***1-4 hours*** - This timeframe is recommended to **minimize the risk of bacterial growth** in the blood product, as bacteria can multiply quickly at room temperature. - Completing the transfusion within 4 hours also reduces the likelihood of **red blood cell degeneration** and loss of efficacy. *3-6 hours* - This period extends beyond the recommended maximum of 4 hours, increasing the risk of **bacterial proliferation** in the blood product. - Prolonged infusion times can also lead to a **decrease in the viability and function** of transfused cells. *4-8 hours* - Transfusing over 4-8 hours significantly elevates the risk of **bacterial contamination** and potential septic reactions. - The extended duration compromises the **quality and safety** of the blood product. *8-12 hours* - This timeframe is unacceptably long for a blood transfusion, posing a **critical risk of severe bacterial growth** and infection. - Blood products should not be administered beyond 4 hours due to the rapid decline in **cell integrity and increased adverse reaction potential**.

Q: Parachute lesions are associated with which of the following conditions?

Eale's disease. ***Eale's disease*** - **Eale's disease** is an idiopathic retinal perivasculitis affecting young males, characterized by recurrent vitreous hemorrhages. - In the context of this question (NEET-2013), the term "parachute lesions" refers to the characteristic pattern of hemorrhages seen in Eale's disease. - The disease features retinal periphlebitis, capillary non-perfusion, and neovascularization leading to vitreous hemorrhage. - **Note:** The term "parachute hemorrhages" in broader ophthalmology typically describes preretinal/subhyaloid hemorrhages that settle inferiorly (boat-shaped), more commonly seen in proliferative diabetic retinopathy. *Diabetes* - **Diabetic retinopathy** presents with microaneurysms, dot-blot hemorrhages, hard exudates, cotton-wool spots, and neovascularization. - While proliferative diabetic retinopathy can cause preretinal "parachute-shaped" hemorrhages (boat-shaped hemorrhages that settle inferiorly), this is not the association being tested in this NEET-2013 question. - The specific context of this exam question associates the term with Eale's disease. *Sickle cell anemia* - **Sickle cell retinopathy** features characteristic sea-fan neovascularization in the peripheral retina. - Can cause salmon-patch hemorrhages, black sunburst lesions, and angioid streaks. - While vitreous hemorrhage can occur, "parachute lesions" is not standard terminology for sickle cell retinopathy manifestations. *None of the options* - This option is incorrect because **Eale's disease** is the correct answer according to the NEET-2013 exam key.

Question 1

Which of the following is a characteristic finding in distal RTA?

Accepted Answer

Hypercalciuria

Answer

Urine pH < 5.5

Answer

Hypokalemia

Answer

Nephrolithiasis

Question 2

Which of the following is not a feature of distal renal tubular acidosis

Accepted Answer

Hyperkalemia

Answer

Renal hypercalciuria

Answer

Normal anion gap

Answer

Alkaline urine

Question 3

Hyperkalemia aciduria is seen in

Accepted Answer

Type IV Renal Tubular Acidosis

Answer

Type I Renal Tubular Acidosis

Answer

Sigmoidocolostomy procedure

Answer

Type II Renal Tubular Acidosis

Question 4

A diabetic patient presents with hyperkalemia and urinary pH < 5.5. What is the MOST likely underlying cause?

Accepted Answer

Type IV RTA

Answer

Uremia

Answer

Primary hyperaldosteronism

Answer

Type I Renal tubular acidosis

Question 5

Calciphylaxis is a severe life-threatening condition. Which of the following is most commonly associated with it?

Accepted Answer

End stage Renal disease

Answer

Parathyroidectomy

Answer

Medullary carcinoma thyroid

Answer

Hyperthyroidism

Question 6

What is the primary clinical feature of Henoch-Schonlein purpura?

Accepted Answer

Skin rash characterized by palpable purpura

Answer

Abdominal pain due to vasculitis

Answer

Joint pain associated with the condition

Answer

Kidney involvement in the disease

Question 7

Interstitial nephritis is common with

Accepted Answer

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Answer

Black water fever

Answer

Rhabdomyolysis

Answer

Tumor lysis syndrome

Question 8

What is the recommended rate of correction for sodium deficit in patients with chronic hyponatremia?

Accepted Answer

0.5 mmol/hour

Answer

1 mmol/hour

Answer

1.5 mmol/hour

Answer

2.0 mmol/hour

Question 9

What is the recommended time frame for completing a blood transfusion after initiation?

Accepted Answer

1-4 hours

Answer

3-6 hours

Answer

4-8 hours

Answer

8-12 hours

Question 10

Parachute lesions are associated with which of the following conditions?

Accepted Answer

Eale's disease

Answer

Diabetes

Answer

Sickle cell anemia

Answer

None of the options

NEET-PG 2013

Internal Medicine

Ophthalmology